You don't get $15m without a solid and achievable business plan so I am presuming that management has something that impresses.
At any given time, the amount of money at risk for Roswell will be far lower than 15m as Roswell will likely sell stock on market to recoup their money.
While there are benefits to having convertible notes in certain circumstances, I would encourage holders to look at the share price of companies which have or had comparable convertible note funding facilities. Look at BCC up to Feb 2011 and PRR up to Jan 2011; after those periods, agreements with SpringTree were terminated. Also look at HTX and ESI. The effect of dilutive convertible note funding facilities are not unilaterally bad and share price can actually rise in spite of the ongoing dilution (e.g. see VLA and CBZ) but the company needs to be kicking goals on the fundamentals front and attracting more new buyers into the market. Not being unduly negative here but market has taught me some lessons with CN facilities. All imo of course.
GGP Price at posting:
1.1¢ Sentiment: Hold Disclosure: Held